University of Nebraska Medical Center

Fred & Pamela Buffett Cancer Center

Omaha, NE

Website

(888) 828-2206 Refer Patient

Filters

Help Me Find Trials

Sort by

Accepting patients

KarMMa-2

Phase 2 Clinical Trial Studying the Safety and Efficacy of bb2121 in Participants with Relapsed and Refractory Multiple Myeloma or Clinical High-Risk Multiple Myeloma

Learn more

CAR T Cell
BCMA
High Risk
Phase 2

Not yet accepting

A Phase 1, Multicenter, Open-label Study to Evaluate the Safety and Preliminary Efficacy of BMS-986393 in Novel Combinations in Participants With Relapsed and/or Refractory Multiple Myeloma and Determine the Recommended Dose for Each Add-on Investigational Component

Learn more

CAR T Cell
CELMoD
GPRC5D
Phase 1

Get personalized results in 60 seconds

All clinical trials have eligibility criteria - or a list of reasons why you may be able or unable to participate in a trial. Answer a few questions to view your personalized results - all in under 60 seconds.

Help me find trials

Accepting patients

Iberdomide vs. Observation Post Ide-Cel CAR-T

Randomized Phase 2 Study of Iberdomide Maintenance Therapy Following Idecabtagene Vicleucel CAR-T in Multiple Myeloma Patients

Learn more

CELMoD
Maintenance
Randomization
Phase 2

Accepting patients

PROACTIVE

Promoting Physical Activity to Improve Cognitive Function in Older Adults Undergoing Hematopoietic Cell Transplantation

Learn more

Randomization
Observational Trial

Accepting patients

Prebiotics After Autologous Stem Cell Transplant

A Pilot, Randomized, Double-blind, Placebo-controlled Study Using Prebiotics to Improve Gut Microbiome Diversity After Autologous Stem Cell Transplantation in Multiple Myeloma and Lymphoma: The PRIMAL Trial

Learn more